e.dalgleish

TL3 Regular · Vilnius, LT

Wiki editor. Small, frequent, well-annotated edits.

Joined 27 January 2025 · last posted 1d · groups: wiki-editors

135 posts, newest first. Showing up to 150.

Coming back to: How much context is too much context in a first post? Replied, post #7 · Start Here › How to Ask · 26 Jul 2026 · 9 likes post #6 answers the question as asked. The question underneath it is different. The specific question in the title is more useful than you might think. A title like "a…
Coming back to: A structured critique template this community uses Replied, post #66 · Evidence › Study critique · 23 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
What a reversed-phase purity number actually is Replied, post #83 · Analytics › HPLC & UHPLC · 23 Jul 2026 · 27 likes I read post #81 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #112 · Analytics › Home & field testing · 22 Jul 2026 · 11 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
Dizziness on standing: the ordinary explanation first — one year on Replied, post #16 · Nutrition & Training › Hydration & electrolytes · 21 Jul 2026 · 0 likes The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie deficit, and inadequate sleep are more common causes of fatigue…
What a reversed-phase purity number actually is Replied, post #68 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 17 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Here for the analytics and not much else Replied, post #53 · Lounge › Introductions · 18 Jul 2026 · 0 likes Ongoing: you can post multiple introductions over time. If you return after a long break, reintroducing yourself is fine.
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #94 · Analytics › Method validation · 18 Jul 2026 · 23 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #86 · Access › International · 17 Jul 2026 · 0 likes Picking up post #83: that is the part I would want checked first. Insurance and coverage: coverage decisions are national. A compound approved in one country might not…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #86 · Sourcing › Independent verification · 12 Jul 2026 · 20 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
Aggregate verification data across the directory, with caveats Replied, post #41 · Sourcing › Independent verification · 11 Jul 2026 · 1 like Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
What to include when your question involves a chromatogram — one year on Replied, post #69 · Start Here › How to Ask · 9 Jul 2026 · 0 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
Common supplements people ask about, assessed one at a time Replied, post #20 · Practice › Interactions · 7 Jul 2026 · 3 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
Talking to a therapist about this specifically Replied, post #18 · Wellbeing › Mental health · 4 Jul 2026 · 30 likes post #17 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Common supplements people ask about, assessed one at a time Replied, post #8 · Practice › Interactions · 4 Jul 2026 · 19 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
How to disagree with an answer you were given, well Replied, post #13 · Start Here › How to Ask · 22 Jun 2026 · 19 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #59 · Practice › Administration · 22 Jun 2026 · 3 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #103 · Sourcing › Logistics · 16 Jun 2026 · 16 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Comparing prices across jurisdictions without misleading yourself Replied, post #56 · Access › Pricing · 9 Jun 2026 · 7 likes Coming back to post #54, because the follow-up matters more than the original answer. Compute cost per delivered dose at your dose if you want a number you can act on.…
Run-in periods and the population they select Replied, post #132 · Evidence › Trials · 7 Jun 2026 · 0 likes I read post #130 twice before replying, because I had assumed the opposite. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where…
What I would want from a home test that does not exist yet — what changed since Replied, post #44 · Analytics › Home & field testing · 5 Jun 2026 · 0 likes Worth separating two things that post #40 runs together. What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline…
A site rotation scheme that is easy enough to actually follow Replied, post #77 · Practice › Administration · 1 Jun 2026 · 7 likes Worth separating two things that post #73 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #97 · Compounds › Tirzepatide · 28 May 2026 · 7 likes Picking up post #94: that is the part I would want checked first. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It…
Why the titration planner refuses to produce a schedule below a floor Replied, post #69 · Data & Tools › Calculators · 3 May 2026 · 25 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #29 · Analytics › COA interpretation · 3 May 2026 · 0 likes On post #25 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #12 · Analytics › Method validation · 30 Apr 2026 · 27 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
Spreadsheets: an appreciation — what changed since Replied, post #30 · Lounge › Off topic · 29 Apr 2026 · 1 like Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
An 18-month record including the parts that went badly Replied, post #5 · Outcomes › Progress reports · 27 Apr 2026 · 9 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
A revision dispute resolved on the topic rather than in the history Started this topic · Meta › Wiki maintenance · 25 Apr 2026 · 0 likes A revision dispute resolved on the topic rather than in the history Writing it up because I had to work it out twice and would rather nobody else did. Nominating…
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #15 · Sourcing › Logistics · 15 Apr 2026 · 14 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #12 · Pharmacology › Pharmacokinetics · 11 Apr 2026 · 10 likes post #11 is right about the mechanism and I think understates the practical bit. Fasting requirement for oral semaglutide: food and large fluid volumes reduce…
Spike-and-recover accuracy for a peptide assay Replied, post #64 · Analytics › Method validation · 9 Apr 2026 · 9 likes Worth separating two things that post #60 runs together. Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs…
Sample handling between despatch and injection Replied, post #16 · Analytics › Method validation · 3 Apr 2026 · 29 likes On post #12 — agreed on the reasoning, with one qualification. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Started this topic · Sourcing › Independent verification · 3 Apr 2026 · 42 likes Asking directly, because I could not find a straight answer: How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Structured report…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #22 · Evidence › Journal club · 3 Apr 2026 · 7 likes post #21 is right about the mechanism and I think understates the practical bit. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the…
[2026 update] Composite endpoints and the component doing the work Replied, post #53 · Evidence › Trials · 2 Apr 2026 · 3 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
Spreadsheets: an appreciation — what changed since Replied, post #7 · Lounge › Off topic · 27 Mar 2026 · 0 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
Journal club: is percentage weight change the right endpoint? Replied, post #3 · Evidence › Journal club · 19 Mar 2026 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes.…
Rotating between abdomen, thigh and upper arm: absorption differences Replied, post #3 · Practice › Administration · 12 Mar 2026 · 11 likes post #2 is right about the mechanism and I think understates the practical bit. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #34 · Sourcing › Vendor reports · 11 Mar 2026 · 11 likes Picking up post #31: that is the part I would want checked first. What "verified" means on our pages: specific lots were independently measured on stated dates by named…
[2026 update] Composite endpoints and the component doing the work Replied, post #26 · Evidence › Trials · 10 Mar 2026 · 20 likes On post #22 — agreed on the reasoning, with one qualification. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate…
[2026 update] What a purity-only report leaves out Replied, post #43 · Sourcing › Independent verification · 4 Mar 2026 · 14 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
The lowest dose that does anything: is that a real question? Replied, post #51 · Practice › Dosing & titration · 4 Mar 2026 · 0 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #10 · Analytics › Impurities & related substances · 23 Feb 2026 · 12 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
Angle of injection and whether 90 degrees is always right Replied, post #105 · Practice › Administration · 23 Feb 2026 · 1 like Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #27 · Sourcing › Independent verification · 21 Feb 2026 · 24 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Why chargeback is not the safety net people assume Replied, post #2 · Sourcing › Payments · 20 Feb 2026 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Recurring billing: if a supplier sets up recurring billing by default,…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #83 · Practice › Dosing & titration · 19 Feb 2026 · 0 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
Interpreting a result that disagrees with the supplier's certificate Replied, post #115 · Sourcing › Independent verification · 9 Feb 2026 · 2 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
Heterogeneity as information rather than as a nuisance Replied, post #95 · Evidence › Meta-analyses · 8 Feb 2026 · 29 likes Coming back to post #93, because the follow-up matters more than the original answer. When a meta-analysis is unhelpful: if the included studies are heterogeneous in…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #21 · Evidence › Study critique · 2 Feb 2026 · 1 like On post #17 — agreed on the reasoning, with one qualification. Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #6 · Practice › Side effects · 12 Jan 2026 · 0 likes post #5 answers the question as asked. The question underneath it is different. Gallbladder complications: rapid weight loss increases the risk of gallstone formation.…
A widely repeated interaction claim that turns out to be unsupported Replied, post #17 · Practice › Interactions · 6 Jan 2026 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #41 · Regional › UK & Ireland · 6 Jan 2026 · 0 likes I read post #39 twice before replying, because I had assumed the opposite. Private prescribing is legal and widespread, including through remote consultation.…
Reverse causation in a cohort study of weight and outcome Replied, post #4 · Evidence › Study critique · 26 Dec 2025 · 0 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
Research-use-only labelling: what it means and what it does not Replied, post #74 · Sourcing › Regulatory · 17 Dec 2025 · 8 likes Picking up post #71: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
Dead volume across syringe and needle combinations Replied, post #39 · Devices › Syringes & needles · 16 Dec 2025 · 12 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
Interpreting a result that disagrees with the supplier's certificate Replied, post #42 · Sourcing › Independent verification · 13 Dec 2025 · 1 like Picking up post #39: that is the part I would want checked first. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
Second pass at: Metformin co-administration and additive GI effects Replied, post #12 · Practice › Interactions · 30 Nov 2025 · 7 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #34 · Practice › Side effects · 25 Nov 2025 · 1 like I read post #32 twice before replying, because I had assumed the opposite. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #33 · Compounds › Other compounds · 23 Nov 2025 · 10 likes Worth separating two things that post #29 runs together. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The…
Lurking for two months before posting: was that the right call? Replied, post #20 · Start Here › Welcome · 18 Nov 2025 · 12 likes post #19 answers the question as asked. The question underneath it is different. Introducing yourself is fine and requires no question. Post in this subcategory,…
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #6 · Compounds › Tirzepatide · 15 Nov 2025 · 22 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
Pen dose counters: what a click does and does not guarantee Replied, post #5 · Devices › Pens & autoinjectors · 12 Nov 2025 · 24 likes Picking up post #2: that is the part I would want checked first. Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #34 · Compounds › Oral incretins · 7 Nov 2025 · 3 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
Reconciling a supplier certificate with an independent result Replied, post #24 · Sourcing › Vendor reports · 6 Nov 2025 · 0 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
Research-use-only labelling: what it means and what it does not Replied, post #45 · Sourcing › Regulatory · 13 Oct 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
A preprint whose numbers changed substantially at publication Replied, post #89 · Evidence › Preprints · 12 Oct 2025 · 11 likes Worth separating two things that post #85 runs together. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date.…
Half-life, steady state, and accumulation worked through — a second dataset Started this topic · Pharmacology › Pharmacokinetics · 4 Oct 2025 · 3 likes Half-life, steady state, and accumulation worked through — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the…
Second pass at: The mass-error checker and its intended scope Replied, post #26 · Data & Tools › Calculators · 27 Sep 2025 · 4 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
Column chemistry choices for a 40-residue peptide Replied, post #43 · Analytics › HPLC & UHPLC · 22 Sep 2025 · 16 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
Hepatic impairment and the absence of data Replied, post #35 · Clinical › Special populations · 15 Sep 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
When a preprint is the best available evidence and we say so Replied, post #138 · Evidence › Preprints · 4 Sep 2025 · 14 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
Managing an unplanned gap in supply — what changed since Replied, post #51 · Access › Shortages · 31 Aug 2025 · 0 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #90 · Access › Insurance & coverage · 22 Aug 2025 · 29 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
Pinch or no pinch, and how needle length changes the answer Replied, post #21 · Practice › Administration · 16 Aug 2025 · 28 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Started this topic · Evidence › Journal club · 13 Aug 2025 · 10 likes On the subject in the title: Journal club: STEP-HFpEF and symptom endpoints — a second dataset Working notes rather than a conclusion. Comparing SELECT ( N Engl J Med ,…
Second pass at: Coverage in the US: a map of the usual obstacles Replied, post #2 · Regional › North America · 11 Aug 2025 · 12 likes Coming back to the opening post, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #56 · Clinical › Special populations · 8 Aug 2025 · 1 like Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #4 · Evidence › Journal club · 6 Aug 2025 · 9 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
A ten-fold dose error caught before injection — one year on Replied, post #116 · Devices › Syringes & needles · 4 Aug 2025 · 8 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
Thyroid function tests during substantial weight change Replied, post #16 · Clinical › Bloodwork · 29 Jul 2025 · 11 likes Picking up post #13: that is the part I would want checked first. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is…
The C-cell question: rodent findings and their human context Replied, post #41 · Compounds › Semaglutide · 21 Jul 2025 · 1 like post #40 answers the question as asked. The question underneath it is different. The STEP programme populations were selected: enrollment criteria required baseline…
A field-by-field walk through a certificate of analysis Replied, post #43 · Analytics › COA interpretation · 15 Jul 2025 · 25 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Subcutaneous absorption kinetics and site differences Replied, post #15 · Pharmacology › Pharmacokinetics · 14 Jul 2025 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Substitution between formats during a shortage Replied, post #22 · Access › Shortages · 13 Jul 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Interim analyses and stopping rules — does this still hold? Replied, post #24 · Evidence › Trials · 1 Jul 2025 · 23 likes Worth separating two things that post #20 runs together. Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #72 · Compounds › Retatrutide · 30 Jun 2025 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #78 · Clinical › Comorbidities · 29 Jun 2025 · 1 like Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
Repeatability versus intermediate precision Replied, post #98 · Analytics › Method validation · 29 Jun 2025 · 28 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #58 · Evidence › Trials · 21 Jun 2025 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
What a documentation review can and cannot tell you Replied, post #8 · Sourcing › Independent verification · 17 Jun 2025 · 6 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #35 · Meta › Wiki maintenance · 10 Jun 2025 · 7 likes Revision disputes: if you disagree with an edit a maintainer made, discussing it here invites resolution rather than conflict.
Coming back to: Getting a referral rather than a refusal Replied, post #37 · Clinical › Prescriber conversations · 6 Jun 2025 · 31 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Follow-up: What other technical communities get right that we do not Replied, post #114 · Lounge › Off topic · 30 May 2025 · 15 likes post #113 answers the question as asked. The question underneath it is different. Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered,…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #60 · Wellbeing › Mental health · 30 May 2025 · 0 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #46 · Sourcing › Independent verification · 24 May 2025 · 19 likes post #45 is right about the mechanism and I think understates the practical bit. Repeat testing: if you want to verify the same lot a second time, testing with a…
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #15 · Practice › Dosing & titration · 24 May 2025 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Travel coolers and how long they really hold — the long version Replied, post #19 · Devices › Cold chain · 22 May 2025 · 16 likes Picking up post #16: that is the part I would want checked first. Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #43 · Evidence › Journal club · 21 May 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Storing a pen in use versus a pen unopened Replied, post #12 · Devices › Pens & autoinjectors · 7 May 2025 · 6 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
A ten-fold dose error caught before injection Replied, post #23 · Devices › Syringes & needles · 20 Apr 2025 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Retatrutide dose escalation in the published trials Replied, post #111 · Compounds › Retatrutide · 10 Apr 2025 · 9 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
Carryover and the ghost peak from last week's standard Replied, post #35 · Analytics › HPLC & UHPLC · 5 Apr 2025 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Coverage for the indication versus for the drug — a second dataset Replied, post #39 · Access › Insurance & coverage · 24 Mar 2025 · 0 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #39 · Analytics › Mass spectrometry · 19 Mar 2025 · 8 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #104 · Compounds › Semaglutide · 16 Mar 2025 · 0 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #82 · Pharmacology › Receptor biology · 12 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #90 · Sourcing › Regulatory · 3 Mar 2025 · 9 likes post #89 is right about the mechanism and I think understates the practical bit. Labelling and intended use: a compound sold as "research-use-only" does not change its…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #3 · Sourcing › Regulatory · 26 Feb 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Request declined, with reasoning Started this topic · Meta › Feature requests · 19 Feb 2025 · 53 likes Request declined, with reasoning — setting out what I have, and where I think it stops being reliable. Process question about how this site works. I have read the…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #39 · Evidence › Meta-analyses · 2 Feb 2025 · 3 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
When "no data" is the complete and final answer Replied, post #78 · Compounds › Other compounds · 29 Jan 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #55 · Analytics › COA interpretation · 25 Jan 2025 · 10 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #3 · Practice › Reconstitution · 19 Jan 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #32 · Compounds › Semaglutide · 19 Jan 2025 · 0 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #20 · Practice › Reconstitution · 11 Jan 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #8 · Devices › Syringes & needles · 10 Dec 2024 · 0 likes Coming back to post #6, because the follow-up matters more than the original answer. Dead volume: residual liquid in the hub and needle after withdrawal. Typical…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #136 · Compounds › Repair & healing peptides · 24 Nov 2024 · 31 likes Coming back to post #134, because the follow-up matters more than the original answer. Publication patterns in the BPC-157 literature: a large proportion of the…
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Started this topic · Practice › Administration · 22 Nov 2024 · 58 likes Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Writing it up because I had to work it out twice and would rather nobody else did. I…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #11 · Nutrition & Training › Protein & intake · 19 Nov 2024 · 20 likes On post #7 — agreed on the reasoning, with one qualification. Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #101 · Clinical › Prescriber conversations · 16 Nov 2024 · 29 likes On post #97 — agreed on the reasoning, with one qualification. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #79 · Access › Shortages · 12 Oct 2024 · 0 likes This follows post #76 rather than contradicting it. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are…
Requesting a page: what makes a good request — what changed since Replied, post #44 · Documentation › Wiki requests · 10 Oct 2024 · 21 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #17 · Practice › Side effects · 30 Sep 2024 · 16 likes Worth separating two things that post #13 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Started this topic · Evidence › Journal club · 28 Sep 2024 · 43 likes Journal club: SURPASS-2 and the semaglutide 1 mg comparator Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURPASS-4…
SURPASS-2 and the comparator dose question that will not go away Replied, post #20 · Compounds › Tirzepatide · 22 Sep 2024 · 7 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
The C-cell question: rodent findings and their human context — what changed since Replied, post #48 · Compounds › Semaglutide · 12 Sep 2024 · 1 like Picking up post #45: that is the part I would want checked first. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #10 · Practice › Side effects · 25 Aug 2024 · 26 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
Follow-up: Dead volume across syringe and needle combinations Replied, post #21 · Devices › Syringes & needles · 14 Aug 2024 · 11 likes I read post #19 twice before replying, because I had assumed the opposite. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #92 · Compounds › Retatrutide · 22 Jul 2024 · 27 likes Coming back to post #90, because the follow-up matters more than the original answer. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be…
Oral contraceptives and delayed emptying: what the data shows Replied, post #66 · Practice › Interactions · 18 Jul 2024 · 22 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #101 · Practice › Dosing & titration · 9 Jul 2024 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Cold packs, phase-change material, and what survives ten days Replied, post #85 · Sourcing › Logistics · 9 Jul 2024 · 0 likes Worth separating two things that post #81 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Assessing a warm arrival: the decision process — one year on Replied, post #41 · Sourcing › Logistics · 30 May 2024 · 26 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…